Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domain
Open Access
- 15 March 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep44474
Abstract
Botulinum neurotoxins (BoNTs) are the most toxic proteins known, due to inhibiting the neuronal release of acetylcholine and causing flaccid paralysis. Most BoNT serotypes target neurons by binding to synaptic vesicle proteins and gangliosides via a C-terminal binding sub-domain (HCC). However, the role of their conserved N-terminal sub-domain (HCN) has not been established. Herein, we created a mutant form of recombinant BoNT/A lacking HCN (rAΔHCN) and showed that the lethality of this mutant is reduced 3.3 × 104-fold compared to wild-type BoNT/A. Accordingly, low concentrations of rAΔHCN failed to bind either synaptic vesicle protein 2C or neurons, unlike the high-affinity neuronal binding obtained with 125I-BoNT/A (Kd = 0.46 nM). At a higher concentration, rAΔHCN did bind to cultured sensory neurons and cluster on the surface, even after 24 h exposure. In contrast, BoNT/A became internalised and its light chain appeared associated with the plasmalemma, and partially co-localised with vesicle-associated membrane protein 2 in some vesicular compartments. We further found that a point mutation (W985L) within HCN reduced the toxicity over 10-fold, while this mutant maintained the same level of binding to neurons as wild type BoNT/A, suggesting that HCN makes additional contributions to productive internalization/translocation steps beyond binding to neurons.Keywords
This publication has 42 references indexed in Scilit:
- Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cellsJournal of Neurochemistry, 2013
- Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A)PLOS Pathogens, 2013
- A botulinum toxin–derived targeted secretion inhibitor downregulates the GH/IGF1 axisJournal of Clinical Investigation, 2012
- Receptor Binding Enables Botulinum Neurotoxin B to Sense Low pH for Translocation Channel AssemblyCell Host & Microbe, 2011
- A Dileucine in the Protease of Botulinum Toxin A Underlies Its Long-lived NeuroparalysisJournal of Biological Chemistry, 2011
- Botulinum Neurotoxin: A Marvel of Protein DesignAnnual Review of Biochemistry, 2010
- Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into NeuronsMolecular Biology of the Cell, 2008
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- Protein production by auto-induction in high-density shaking culturesProtein Expression and Purification, 2005
- Sequence homology and structural analysis of the clostridial neurotoxinsJournal of Molecular Biology, 1999